The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare
Open accessAbstract
The landscape of medical treatments is undergoing a transformative shift. Precision medicine has ushered in a revolutionary era in healthcare by individualizing diagnostics and treatments according to each patient’s uniquely evolving health status. This groundbreaking method of tailoring disease prevention and treatment considers individual variations in genes, environments, and lifestyles. The goal of precision medicine is to target the “five rights”: the right patient, the right drug, the right time, the right dose, and the right route. In this pursuit, in silico techniques have emerged as an anchor, driving precision medicine forward and making this a realistic and promising avenue for personalized therapies. With the advancements in high-throughput DNA sequencing technologies, genomic data, including genetic variants and their interactions with each other and the environment, can be incorporated into clinical decision-making. Pharmacometrics, gathering pharmacokinetic (PK) and pharmacodynamic (PD) data, and mathematical models further contribute to drug optimization, drug behavior prediction, and drug–drug interaction identification. Digital health, wearables, and computational tools offer continuous monitoring and real-time data collection, enabling treatment adjustments. Furthermore, the incorporation of extensive datasets in computational tools, such as electronic health records (EHRs) and omics data, is also another pathway to acquire meaningful information in this field. Although they are fairly new, machine learning (ML) algorithms and artificial intelligence (AI) techniques are also resources researchers use to analyze big data and develop predictive models. This review explores the interplay of these multiple in silico approaches in advancing precision medicine and fostering individual healthcare. Despite intrinsic challenges, such as ethical considerations, data protection, and the need for more comprehensive research, this marks a new era of patient-centered healthcare. Innovative in silico techniques hold the potential to reshape the future of medicine for generations to come.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiomics: Images Are More than Pictures, They Are Data
Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016) · Radiology · doi:10.1148/radiol.2015151169 · Cited by 8,421
Machine learning: Algorithms, real-world applications and research directions
Sarker, I. H. (2021) · SN Computer Science · doi:10.1007/s42979-021-00592-x · Cited by 5,583 · cited 2×
“Unlike theory-driven methods, these approaches prioritize empirical relationships and statistical methods, enabling pharmacometricians to capture complex interactions between drug concentrations and patient-specific factors for more accurate parameter estimates [147].”
BackgroundDevelopment of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Metabolomics: beyond biomarkers and towards mechanisms
Johnson, C. H., Ivanisevic, J., & Siuzdak, G. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.25 · Cited by 2,829
Interpreting Black-Box Models: A Review on Explainable Artificial Intelligence
Hassija, V., Chamola, V., Mahapatra, A., Singal, A., Goel, D., Huang, K., Scardapane, S., Spinelli, I., Mahmud, M., & Hussain, A. (2024) · Cognitive Computation · doi:10.1007/s12559-023-10179-8 · Cited by 2,495 · cited 1×
“Advanced models can play a pivotal role in verifying the accurate application of de-identification techniques, thereby promoting both data confidentiality and usability while aligning with ethical and regulatory standards [214].”
BackgroundPrecision medicine, AI, and the future of personalized health care
Johnson, K. B., Wei, W., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K., Zhao, J., & Snowdon, J. L. (2021) · Clinical and Translational Science · doi:10.1111/cts.12884 · Cited by 1,854
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Rigatti, S. J. (2017) · Journal of Insurance Medicine · doi:10.17849/insm-47-01-31-39.1 · Cited by 1,801
Why 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
A model of inexact reasoning in medicine
Shortliffe, E. H., & Buchanan, B. G. (1975) · Mathematical Biosciences · doi:10.1016/0025-5564(75)90047-4 · Cited by 1,447
Internist-I, an Experimental Computer-Based Diagnostic Consultant for General Internal Medicine
Miller, R. A., Pople, H. E., & Myers, J. D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198208193070803 · Cited by 1,127
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Woodcock, J., & LaVange, L. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1510062 · Cited by 1,020
Personalized medicine: motivation, challenges, and progress
Goetz, L. H., & Schork, N. J. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.006 · Cited by 976
Addressing bias in big data and AI for health care: A call for open science
Norori, N., Hu, Q., Aellen, F. M., Faraci, F. D., & Tzovara, A. (2021) · Patterns · doi:10.1016/j.patter.2021.100347 · Cited by 903
Mould, D., & Upton, R. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.14 · Cited by 897
Adaptive designs in clinical trials: why use them, and how to run and report them
Pallmann, P., Bedding, A. W., Choodari-Oskooei, B., Dimairo, M., Flight, L., Hampson, L. V., Holmes, J., Mander, A. P., Odondi, L., Sydes, M. R., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1017-7 · Cited by 829
Rodríguez-Pérez, R., & Bajorath, J. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00314-0 · Cited by 718
Aldoseri, A., Al-Khalifa, K. N., & Hamouda, A. M. (2023) · Applied Sciences · doi:10.3390/app13127082 · Cited by 716
Seyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 713
Estimation of population characteristics of pharmacokinetic parameters from routine clinical data
Sheiner, L. B., Rosenberg, B., & Marathe, V. V. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061728 · Cited by 700
Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
Jones, H., & Rowland‐Yeo, K. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.41 · Cited by 626
Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development
Mould, D., & Upton, R. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.4 · Cited by 544
The next generation of evidence-based medicine
Subbiah, V. (2023) · Nature Medicine · doi:10.1038/s41591-022-02160-z · Cited by 544
Enabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517
Park, J. J. H., Siden, E., Zoratti, M. J., Dron, L., Harari, O., Singer, J., Lester, R. T., Thorlund, K., & Mills, E. J. (2019) · Trials · doi:10.1186/s13063-019-3664-1 · Cited by 441
Ferrell, P. B., & McLeod, H. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.10.1543 · Cited by 439
Petersson, L., Larsson, I., Nygren, J. M., Nilsen, P., Neher, M., Reed, J. E., Tyskbo, D., & Svedberg, P. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08215-8 · Cited by 434
Evaluation of artificial intelligence techniques in disease diagnosis and prediction
Ghaffar Nia, N., Kaplanoglu, E., & Nasab, A. (2023) · Discover Artificial Intelligence · doi:10.1007/s44163-023-00049-5 · Cited by 426
Aronson, J. K., & Ferner, R. E. (2017) · Current Protocols in Pharmacology · doi:10.1002/cpph.19 · Cited by 417
PBPK modeling and simulation in drug research and development
Zhuang, X., & Lu, C. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.04.004 · Cited by 410
Clinical Decision Support Systems for Improving Diagnostic Accuracy and Achieving Precision Medicine
Castaneda, C., Nalley, K., Mannion, C., Bhattacharyya, P., Blake, P., Pecora, A., Goy, A., & Suh, K. S. (2015) · Journal of Clinical Bioinformatics · doi:10.1186/s13336-015-0019-3 · Cited by 408
Jarada, T. N., Rokne, J. G., & Alhajj, R. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00450-7 · Cited by 384
Explainable, trustworthy, and ethical machine learning for healthcare: A survey
Rasheed, K., Qayyum, A., Ghaly, M., Al-Fuqaha, A., Razi, A., & Qadir, J. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106043 · Cited by 372
SHIFTing artificial intelligence to be responsible in healthcare: a systematic review
Siala, H., & Wang, Y. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.114782 · Cited by 358
Personalized Medicine and the Power of Electronic Health Records
Abul-Husn, N. S., & Kenny, E. E. (2019) · Cell · doi:10.1016/j.cell.2019.02.039 · Cited by 355
Precision medicine in 2030—seven ways to transform healthcare
Denny, J. C., & Collins, F. S. (2021) · Cell · doi:10.1016/j.cell.2021.01.015 · Cited by 353
Pharmacogenomics: current status and future perspectives
Pirmohamed, M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00572-8 · Cited by 351
Digitization of healthcare sector: A study on privacy and security concerns
Paul, M., Maglaras, L., Ferrag, M. A., & Almomani, I. (2023) · ICT Express · doi:10.1016/j.icte.2023.02.007 · Cited by 347
Gabrielsson, J., & Weiner, D. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-050-2_16 · Cited by 328
Accessing Artificial Intelligence for Clinical Decision-Making
Giordano, C., Brennan, M., Mohamed, B., Rashidi, P., Modave, F., & Tighe, P. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.645232 · Cited by 326
Sheiner, L. B., & Beal, S. L. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061030 · Cited by 306
Clinical trial design in the era of precision medicine
Fountzilas, E., Tsimberidou, A. M., Vo, H. H., & Kurzrock, R. (2022) · Genome Medicine · doi:10.1186/s13073-022-01102-1 · Cited by 305
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review
Kolluri, S., Lin, J., Liu, R., Zhang, Y., & Zhang, W. (2022) · The AAPS Journal · doi:10.1208/s12248-021-00644-3 · Cited by 286
The role of machine learning in clinical research: transforming the future of evidence generation
Weissler, E. H., Naumann, T., Andersson, T., Ranganath, R., Elemento, O., Luo, Y., Freitag, D. F., Benoit, J., Hughes, M. C., Khan, F., et al. (2021) · Trials · doi:10.1186/s13063-021-05489-x · Cited by 280
Sands, B. E., Chen, J., Feagan, B. G., Penney, M., Rees, W. A., Danese, S., Higgins, P. D. R., Newbold, P., Faggioni, R., Patra, K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.049 · Cited by 279
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
Meibohm, B., & Derendorf, H. (1997) · PubMed · Cited by 276
Renfro, L. A., & Sargent, D. J. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw413 · Cited by 271
Early lung cancer diagnostic biomarker discovery by machine learning methods
Xie, Y., Meng, W.-Y., Li, R.-Z., Wang, Y.-W., Qian, X., Chan, C., Yu, Z.-F., Fan, X.-X., Pan, H.-D., Xie, C., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2020.100907 · Cited by 269
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
Kwon, Y. W., Jo, H.-S., Bae, S., Seo, Y., Song, P., Song, M., & Yoon, J. H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.747333 · Cited by 268
Upton, R., & Mould, D. (2014) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.71 · Cited by 265
Population Pharmacokinetics I: Background, Concepts, and Models
Ette, E. I., & Williams, P. J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d374 · Cited by 249
Binuya, M. A. E., Engelhardt, E. G., Schats, W., Schmidt, M. K., & Steyerberg, E. W. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01801-8 · Cited by 246
Lecomte, T., Ferraz, J.-M., Zinzindohoué, F., Loriot, M.-A., Tregouet, D.-A., Landi, B., Berger, A., Cugnenc, P.-H., Jian, R., Beaune, P., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0169 · Cited by 242
Tuntland, T., Ethell, B., Kosaka, T., Blasco, F., Zang, R. X., Jain, M., Gould, T., & Hoffmaster, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00174 · Cited by 239 · cited 1×
“Even at the initial stages, during the discovery of novel compounds phase, these strategies can be effectively implemented [97].”
BackgroundTechnology approaches to digital health literacy.
Dunn, P., & Hazzard, E. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.06.039 · Cited by 232 · cited 1×
“…technologies such as wearable devices, mobile health, telehealth, health information technology, telemedicine, apps, sensors, data analysis, and other digital solutions to improve the delivery of healthcare services, raise the quality of patient care, and optimize healthcare management [230,231].”
BackgroundDiagnostic and Prognostic Epigenetic Biomarkers in Cancer
Costa-Pinheiro, P., Montezuma, D., Henrique, R., & Jerónimo, C. (2015) · Epigenomics · doi:10.2217/epi.15.56 · Cited by 231
Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs
Ochoa, D., Karim, M., Ghoussaini, ., Hulcoop, D. G., McDonagh, E. M., & Dunham, I. (2022) · Nature Reviews Drug Discovery · doi:10.1038/d41573-022-00120-3 · Cited by 231
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
Flockhart, D. A., O'Kane, D., Williams, M. S., Watson, M. S., Flockhart, D. A., Gage, B., Gandolfi, R., King, R., Lyon, E., Nussbaum, R., et al. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e318163c35f · Cited by 227
The use of machine learning in rare diseases: a scoping review
Schaefer, J., Lehne, M., Schepers, J., Prasser, F., & Thun, S. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01424-6 · Cited by 213 · cited 1×
“Therefore, the fact that decision-making on treatment strategies may be supported by this type of model also enables questions related to complex medical cases or rare diseases to be addressed [85], where available clinical data is limited [181].”
BackgroundHoque, M. O., Begum, S., Topaloglu, O., Jeronimo, C., Mambo, E., Westra, W. H., Califano, J. A., & Sidransky, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0799 · Cited by 213
Tebani, A., Afonso, C., Marret, S., & Bekri, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091555 · Cited by 212
Bauer, R. J., Guzy, S., & Ng, C. (2007) · The AAPS Journal · doi:10.1208/aapsj0901007 · Cited by 204
4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
Diczfalusy, U., Nylén, H., Elander, P., & Bertilsson, L. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03773.x · Cited by 202
Salahudeen, M. S., & Nishtala, P. S. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2016.07.002 · Cited by 191
Data Integration Challenges for Machine Learning in Precision Medicine
Martínez-García, M., & Hernández-Lemus, E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.784455 · Cited by 185
WHO guidance for digital health: What it means for researchers
Jandoo, T. (2020) · DIGITAL HEALTH · doi:10.1177/2055207619898984 · Cited by 184
Niazi, S. K. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s424991 · Cited by 184
Poweleit, E. A., Vinks, A. A. T. M. M., & Mizuno, T. (2023) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001078 · Cited by 180
Chien, J. Y., Friedrich, S., Heathman, M. A., de Alwis, D. P., & Sinha, V. (2005) · The AAPS Journal · doi:10.1208/aapsj070355 · Cited by 178
Digital Health Data Quality Issues: Systematic Review
Syed, R., Eden, R., Makasi, T., Chukwudi, I., Mamudu, A., Kamalpour, M., Geeganage, D. K., Sadeghianasl, S., Leemans, S. J. J., Goel, K., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/42615 · Cited by 174
Biomarkers of inflammation and the etiology of sepsis
Grondman, I., Pîrvu, A., Riza, A. L., Ioana, M. I., & Netea, M. G. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190029 · Cited by 172
Precision medicine: Concept and tools
Naithani, N., Sinha, S., Misra, P., Vasudevan, B., & Sahu, R. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.06.021 · Cited by 172
Delpierre, C., & Lefèvre, T. (2023) · Frontiers in Sociology · doi:10.3389/fsoc.2023.1112159 · Cited by 167
Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
Zou, H., Banerjee, P., Leung, S. S. Y., & Yan, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00997 · Cited by 161
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables
Tyson, R., Park, C. C., Powell, J. R., Patterson, J. H., Weiner, D., Watkins, P. B., & González, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00420 · Cited by 160
FDA Approval Summary: Palbociclib for Male Patients with Metastatic Breast Cancer
Wedam, S., Fashoyin-Aje, L., Bloomquist, E., Tang, S., Sridhara, R., Goldberg, K. B., Theoret, M. R., Amiri-Kordestani, L., Pazdur, R., & Beaver, J. A. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2580 · Cited by 158
Clinical Trial Generalizability Assessment in the Big Data Era: A Review
He, Z., Tang, X. D., Yang, X., Guo, Y. M., George, T. J., Charness, N. H., Bartley, K., Hogan, W. R., & Bian, J. (2020) · Clinical and Translational Science · doi:10.1111/cts.12764 · Cited by 158
Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
Dagenais, S., Russo, L., Madsen, A. M., Webster, J., & Becnel, L. B. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2480 · Cited by 155
Lu, S.-C., Swisher, C. L., Chung, C. D., Jaffray, D. A., & Sidey-Gibbons, C. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1129380 · Cited by 148
Lauschke, V. M., Zhou, Y., & Ingelman‐Sundberg, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.002 · Cited by 146
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
Maria, R. D., Sante, G. D., Piro, G., Carbone, C., Tortora, G., Boldrini, L., Pietragalla, A., Daniele, G., Tredicine, M., Cesario, A., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030216 · Cited by 143
Collin, C. B., Gebhardt, T., Golebiewski, M., Karaderi, T., Hillemanns, M., Khan, F. M., Salehzadeh‐Yazdi, A., Kirschner, M. W., Krobitsch, S., & Kuepfer, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020166 · Cited by 143
Miller, N. A., Reddy, M. B., Heikkinen, A. T., Lukacova, V., & Parrott, N. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00741-9 · Cited by 142 · cited 1×
“…which often require extensive trial-and-error adjustments to find optimal dosages [154,155], these methods accelerate this process, reducing costs and risks, and can be used in early drug development stages to predict PK parameters, facilitating decision-making and dose selection [156,157].”
BackgroundFundamentals of Population Pharmacokinetic Modelling: Validation Methods
Sherwin, C. M. T., Kiang, T. K. L., Spigarelli, M. G., & Ensom, M. H. H. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261932 · Cited by 138
Lin, W., Chen, Y., Unadkat, J. D., Zhang, X., Wu, D., & Heimbach, T. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03274-2 · Cited by 137
Today’s Challenges to De-Risk and Predict Drug Safety in Human “Mind-the-Gap”
Weaver, R. J., & Valentin, J. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy270 · Cited by 133
Master protocol trials in oncology: Review and new trial designs
Hirakawa, A., Asano, J., Sato, H., & Teramukai, S. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.08.009 · Cited by 131
Machine Learning in Pharmacometrics: Opportunities and Challenges
McComb, M., Bies, R., & Ramanathan, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14801 · Cited by 128 · cited 3×
“This not only reduces the time required for model development and refinement, but also handles large datasets and a multitude of potential covariates more comprehensively than manual meth-ods [168].”
BackgroundInfluentialEthical Issues in Patient Data Ownership
Chiruvella, V., & Guddati, A. K. (2021) · Interactive Journal of Medical Research · doi:10.2196/22269 · Cited by 127
Brnabic, A., & Hess, L. M. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01403-2 · Cited by 123
Privacy Protection and Secondary Use of Health Data: Strategies and Methods
Xiang, D., & Cai, W. M. (2021) · BioMed Research International · doi:10.1155/2021/6967166 · Cited by 123
The wholeness in suffix -omics, -omes, and the word om.
Yadav, S. P. (2007) · PubMed · Cited by 119
Precision Medicine: A New Paradigm in Therapeutics
Akhoon, N. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_375_19 · Cited by 117
Multi-omics profiling: the way toward precision medicine in metabolic diseases
Hu, C., & Jia, W. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab051 · Cited by 117
Tacrolimus Exposure Prediction Using Machine Learning
Woillard, J., Labriffe, M., Debord, J., & Marquet, P. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2123 · Cited by 112
The future is now? Clinical and translational aspects of “Omics” technologies
D’Adamo, G. L., Widdop, J. T., & Giles, E. M. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12404 · Cited by 110
Feng, Y., Wang, X., Bajaj, G., Agrawal, S., Bello, A., Lestini, B. J., Finckenstein, F. G., Park, J.-S., & Roy, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2842 · Cited by 109
Keutzer, L., You, H., Farnoud, A., Nyberg, J., Wicha, S. G., Maher‐Edwards, G., Vlasakakis, G., Moghaddam, G. K., Svensson, E. M., Menden, M. P., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081530 · Cited by 109
Precision Medicine: Changing the way we think about healthcare
Gameiro, G. R., Sinkunas, V., Liguori, G. R., & Júnior, J. O. C. A. (2018) · Clinics · doi:10.6061/clinics/2017/e723 · Cited by 108
Uster, D. W., STOCKER, S. L., Carland, J. E., Brett, J., Marriott, D. J. E., Day, R. O., & Wicha, S. G. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2065 · Cited by 107
Peters, S. A., & Dolgos, H. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00790-0 · Cited by 100
Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities
Terranova, N., Venkatakrishnan, K., & Benincosa, L. J. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00593-x · Cited by 98
Disease Progression Modeling: Key Concepts and Recent Developments
Cook, S. F., & Bies, R. R. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0066-x · Cited by 97
Understanding patient engagement in health system decision-making: a co-designed scoping review
McCarron, T. L., Moffat, K., Wilkinson, G., Zelinsky, S., Boyd, J. M., White, D., Hassay, D. N., Lorenzetti, D., Marlett, N. J., & NOSEWORTHY, T. W. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0994-8 · Cited by 97
Sitapati, A. M., Kim, H., Berkovich, B., Marmor, R. A., Singh, S., El-Kareh, R. E., Clay, B. J., & Lucila Ohno-machado, A. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1378 · Cited by 94
Covariate Pharmacokinetic Model Building in Oncology and its Potential Clinical Relevance
Joerger, M. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9320-2 · Cited by 92
Liu, Q., Huang, R., Hsieh, J., Zhu, H., Tiwari, M., Liu, G., Jean, D., ElZarrad, M. K., Fakhouri, T. H. I., Berman, S., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2668 · Cited by 92
Redman, M. W., & Allegra, C. J. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.07.009 · Cited by 91
Tan, Y., Worley, R. R., Leonard, J. A., & Fisher, J. W. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy010 · Cited by 90
The Five Rights: A Destination Without a Map
Grissinger, M. C. (2010) · PubMed Central · Cited by 88
Cloud Computing Enabled Big Multi-Omics Data Analytics
Koppad, S., Annappa, B., Gkoutos, G. V., & Acharjee, A. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211035921 · Cited by 88
Person Centered Care and Personalized Medicine: Irreconcilable Opposites or Potential Companions?
El-Alti, L., Sandman, L., & Munthe, C. (2017) · Health Care Analysis · doi:10.1007/s10728-017-0347-5 · Cited by 85
Fabbiani, M., Giambenedetto, S. D., Bracciale, L., Bacarelli, A., Ragazzoni∘, E., Cauda, R., Navarra, P., & Luca, A. D. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp132 · Cited by 83
Gao, H., Wang, W., Dong, J. N., Ye, Z., & Ouyang, D. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.001 · Cited by 82
Mycophenolic Acid Exposure Prediction Using Machine Learning
Woillard, J., Labriffe, M., Debord, J., & Marquet, P. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2216 · Cited by 77
Gobburu, J. V. S., & Chen, E. P. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950433d · Cited by 76
Hofer, I. S., Burns, M. L., Kendale, S. M., & Wanderer, J. P. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004575 · Cited by 76
Personalized Medicine in Europe
Nimmesgern, E., Benediktsson, I., & Norstedt, I. (2017) · Clinical and Translational Science · doi:10.1111/cts.12446 · Cited by 75
Application of pharmacogenetics in oncology
Miteva-Marcheva, N., Ivanov, H. Y., Dimitrov, D. K., & Stoyanova, V. K. (2020) · Biomarker Research · doi:10.1186/s40364-020-00213-4 · Cited by 75
A New Era of Pharmacovigilance: Future Challenges and Opportunities
Trifirò, G., & Crisafulli, S. (2022) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2022.866898 · Cited by 74
Wu, F. P., Shah, H., Li, M., Duan, P., Zhao, P., Suarez, S., Raines, K., Zhao, Y., Wang, M., Lin, H.-P., et al. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00564-2 · Cited by 70
Sun, H., Depraetere, K., Meesseman, L., Silva, P. C., Szymanowsky, R., Fliegenschmidt, J., Hulde, N., von Dossow, V., Vanbiervliet, M., Baerdemaeker, J. D., et al. (2022) · Journal of Medical Internet Research · doi:10.2196/34295 · Cited by 70
Song, D., Chen, Y., Min, Q., Sun, Q., Ye, K., Zhou, C., Yuan, S., Sun, Z., & Liao, J. (2018) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12786 · Cited by 69
Milestones in Personalized Medicine: From the Ancient Time to Nowadays—the Provocation of COVID-19
Visvikis‐Siest, S., Theodoridou, D., Kontoe, M.-S., Kumar, S., & Marschler, M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.569175 · Cited by 69
Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis
Ahmed, Z. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.02.002 · Cited by 66
Franklin, M. K., & Thorn, J. C. (2019) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0649-9 · Cited by 65
Deep learning for Alzheimer prediction using brain biomarkers
Goenka, N., & Tiwari, S. (2021) · Artificial Intelligence Review · doi:10.1007/s10462-021-10016-0 · Cited by 63
Cucurull‐Sanchez, L., Chappell, M. J., Chelliah, V., Amy Cheung, S. Y., Derks, G., Penney, M., Phipps, A., Malik‐Sheriff, R. S., Timmis, J., Tindall, M. J., et al. (2019) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12381 · Cited by 61 · cited 1×
“Pharmacometrics datasets, frequently developed for specific analysis, face challenges in review and exchange due to their unique construction and lack of standardization [167].”
BackgroundAbouir, K., Samer, C. F., Gloor, Y. S., Desmeules, J. A., & Daali, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708299 · Cited by 60
Identification of in vitro protein biomarkers of idiosyncratic liver toxicity
Gao, J., Garulacan, L. A., Storm, S. M., Hefta, S. A., Opiteck, G. J., Lin, J.-H., Moulin, F., & Dambach, D. M. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.01.012 · Cited by 56
Roche-Lima, A., Roman-Santiago, A., Feliu-Maldonado, R. A., Rodríguez-Maldonado, J., Nieves-Rodríguez, B. G., Carrasquillo-Carrión, K., Ramos, C. M., Sant’Ana, I. D. L., Massey, S. E., & Duconge-Soler, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01550 · Cited by 56
Population pharmacokinetic model selection assisted by machine learning
Sibieude, E., Khandelwal, A., Girard, P., Hesthaven, J. S., & Terranova, N. (2021) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09793-6 · Cited by 56
Phe, K., Heil, E. L., & Tam, V. H. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa118 · Cited by 52
Stone, J. A., Banfield, C. R., Pfister, M., Tannenbaum, S. J., Allerheiligen, S., Wetherington, J. D., Krishna, R., & Grasela, D. M. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010377628 · Cited by 50
Pharmacokinetic/ Pharmacodynamic‐Driven Drug Development
Gallo, J. M. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20193 · Cited by 50
Woods, L. S., Dendere, R., Eden, R., Grantham, B., Krivit, J., Pearce, A., McNeil, K., Green, D., & Sullivan, C. M. (2023) · Journal of Medical Internet Research · doi:10.2196/45868 · Cited by 50
Precision medicine journey through omics approach
Hasanzad, M., Sarhangi, N., Chimeh, S. E., Ayati, N., Afzali, M., Khatami, F., Nikfar, S., & Meybodi, H. R. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00913-0 · Cited by 47
A Machine Learning Approach to Predict Interdose Vancomycin Exposure
Bououda, M., Uster, D. W., Sidorov, E., Labriffe, M., Marquet, P., Wicha, S. G., & Woillard, J. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03252-8 · Cited by 47
Zhu, X., Huang, W., Lu, H., Wang, Z., Ni, X., Hu, J., Deng, S., Tan, Y., Li, L., Zhang, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85157-x · Cited by 46
Pharmacogenomics of antidepressant treatment effects
Licinio, J., & Wong, M. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/jlicinio · Cited by 45
Veng‐Pedersen, P., & Modi, N. B. (1992) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062465 · Cited by 44
Ménard, T., Barmaz, Y., Koneswarakantha, B., Bowling, R., & Popko, L. (2019) · Drug Safety · doi:10.1007/s40264-019-00831-4 · Cited by 44
Phillips, R., Sauzet, O., & Cornelius, V. R. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-01167-9 · Cited by 40
Palmer, M. E., Andrews, L. J., Abbey, T. C., Dahlquist, A., & Wenzler, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888079 · Cited by 40
Siebinga, H., der Veen, B. J. D. W., Stokkel, M. P. M., Huitema, A. D. R., & Hendrikx, J. J. M. A. (2022) · Theranostics · doi:10.7150/thno.77279 · Cited by 39
Umehara, K., Huth, F., Jin, Y., Schiller, H., Aslanis, V., Heimbach, T., & He, H. (2019) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0042 · Cited by 38
CYP2D6 Genotyping and Tamoxifen: An Unfinished Story in the Quest for Personalized Medicine
de Souza, J. A., & Olopade, O. I. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.01.002 · Cited by 37
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective
Dagliati, A., Tibollo, V., Sacchi, L., Malovini, A. L., Limongelli, I., Gabetta, M., Napolitano, C., Mazzanti, A., Cata, P. D., Chiovato, L., et al. (2018) · Frontiers in Digital Humanities · doi:10.3389/fdigh.2018.00008 · Cited by 37
Translational –omics: Future potential and current challenges in precision medicine
Wafi, A., & Mirnezami, R. (2018) · Methods · doi:10.1016/j.ymeth.2018.05.009 · Cited by 37
Freriksen, J. J. M., van der Heijden, J. E. M., de Hoop‐Sommen, M. A., Greupink, R., & de Wildt, S. N. (2022) · Pediatric Drugs · doi:10.1007/s40272-022-00535-w · Cited by 37
Cheng, F., Ma, Y., Uzzi, B., & Loscalzo, J. (2020) · BMC Biology · doi:10.1186/s12915-020-00868-3 · Cited by 36
gPKPDSim: a SimBiology®-based GUI application for PKPD modeling in drug development
Hosseini, I., Gajjala, A., Yadav, D. B., Sukumaran, S., Ramanujan, S., Paxson, R., & Gadkar, K. G. (2018) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9562-9 · Cited by 35
The Generalized Data Model for clinical research
Danese, M. D., Halperin, M., Duryea, J. L., & Duryea, R. (2019) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-019-0837-5 · Cited by 35
Wang, R., Shao, X., Zheng, J., Saci, A., Qian, X., Pak, I., Roy, A., Bello, A., Rizzo, J. I., Hosein, F., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1724 · Cited by 35
Kriegová, E., Kudělka, M., Radvanský, M., & Gallo, J. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02714-8 · Cited by 35
Biomarkers for Clinical Decision-Making in the Management of Pulmonary Embolism
Giannitsis, E., & Katus, H. A. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255240 · Cited by 33
Fernández-Luque, L., Herbish, A. S. A., Shammari, R. A., Argente, J., Bin-Abbas, B. S., Deeb, A., Dixon, D., Zary, N., Koledova, E. B., & Savage, M. O. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.715705 · Cited by 33
Fendt, R., Hofmann, U., Schneider, A. R. P., Schaeffeler, E., Burghaus, R., Yılmaz, A., Blank, L. M., Kerb, R., Lippert, J., Schlender, J., et al. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12646 · Cited by 32
Definitions, components and processes of data harmonisation in healthcare: a scoping review
Schmidt, B., Colvin, C. J., Hohlfeld, A., & Leon, N. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01218-7 · Cited by 30
Leveraging law and ethics to promote safe and reliable AI/ML in healthcare
Drabiak, K. (2022) · Frontiers in Nuclear Medicine · doi:10.3389/fnume.2022.983340 · Cited by 30
Precision dosing to avoid adverse drug reactions
Polasek, T. M., Kirkpatrick, C. M. J., & Rostami‐Hodjegan, A. (2019) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098619894147 · Cited by 29
Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network
Sperber, N. R., Dong, O. M., Roberts, M. C., Dexter, P. R., Elsey, A. R., Ginsburg, G. S., Horowitz, C. R., Johnson, J. A., Levy, K. D., Ong, H. H., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070647 · Cited by 29
Gill, J., Moullet, M., Martinsson, A., Miljković, F. N., Williamson, B., Arends, R. H., & Reddy, V. P. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12884 · Cited by 29
Wedagedera, J. R., Onasanwo, A., Chirumamilla, S. K., Momiji, H., Leary, R. H., Dunlavey, M., Matthews, R., Abduljalil, K., Jamei, M., & Bois, F. Y. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12787 · Cited by 28
Clinical PK/PD modelling as a tool in drug development of corticosteroids.
Derendorf, H., Möllmann, H., Hochhaus, G., Meibohm, B., & Barth, J. (1997) · PubMed · Cited by 27
Vermeulen, E., van den Anker, J. N., Pasqua, O. E. D., Hoppu, K., & van der Lee, J. H. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12637 · Cited by 27
Becker, C., Gross, S., Gamp, M., et al. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07775-z · Cited by 27
Zhu, X., Zhang, M., Wen, Y., & Shang, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.994665 · Cited by 27
Pharmacogenomics in Cardiovascular Diseases
McDonough, C. W. (2021) · Current Protocols · doi:10.1002/cpz1.189 · Cited by 26
Ismail, M., Sale, M. E., Yu, Y., Pillai, N., Liu, S., Pflug, B. R., & Bies, R. R. (2021) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09782-9 · Cited by 25
McComb, M., & Ramanathan, M. K. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1746 · Cited by 23
Mallon, A., Häring, D. A., Dahlke, F., Aarden, P., Afyouni, S., Delbarre, D. J., Emam, K. E., Ganjgahi, H., Gardiner, S., Kwok, C. H., et al. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01409-4 · Cited by 23
Mao, J., Chen, Y., Xu, L., Chen, W., Chen, B., Zhuo, F., Qin, W., & Zhong, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1016399 · Cited by 23
Kim, H. J., Kim, H. J., Park, Y., Lee, W. S., Lim, Y., & Kim, J. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-58088-2 · Cited by 22
Lee, J., Jeong, J.-W., Jung, S., Moon, J., & Rho, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020190 · Cited by 22
Protein and Peptide Biomarkers in Organ Transplantation
Sigdel, T. K., Gao, X., & Sarwal, M. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.29 · Cited by 20
From research cohorts to the patient – a role for “omics” in diagnostics and laboratory medicine?
Vogeser, M., & Bendt, A. K. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1147 · Cited by 20
Rao, P. S., Modi, N., Nguyen, N.-T. T., Vu, D. H., Xie, Y. L., Gandhi, M., Gerona, R. R. L., Metcalfe, J. Z., Heysell, S. K., & Alffenaar, J. C. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01220-y · Cited by 20
Karaulov, A. V., Garib, V., Garib, F. Y., & Valenta, R. (2018) · International Archives of Allergy and Immunology · doi:10.1159/000486856 · Cited by 19
Training the next generation of pharmacometric modelers: a multisector perspective
Bonate, P. L., Barrett, J. S., Ait‐Oudhia, S., Brundage, R. C., Corrigan, B., Duffull, S. B., Gastonguay, M. R., Karlsson, M. O., Kijima, S., Krause, A., et al. (2023) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09878-4 · Cited by 18
Heterogeneity in treatment effects across diverse populations
Nugent, B. M., Madabushi, R., Buch, B., Peiris, V., Crentsil, V., Miller, V. M., Bull, J. C., & Jenkins, M. (2021) · Pharmaceutical Statistics · doi:10.1002/pst.2161 · Cited by 17
Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology
Terranova, N., Girard, P., Ioannou, K., Klinkhardt, U., & Munafo, A. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12284 · Cited by 15
A System to Easily Manage Metadata in Biomedical Research Labs Based on Open-source Software
Castro‐Alamancos, M. A. (2022) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4404 · Cited by 15
The Patient-Centered Decision System as per the 4Ps of Precision Medicine
Baiardini, I., & Heffler, E. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813471-9.00024-4 · Cited by 13
Pitfalls in molecular diagnostics
Sun, L., & Pfeifer, J. D. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.06.002 · Cited by 13
Application of machine learning based methods in exposure–response analysis
Liu, C., Xu, Y., Liu, Q., Zhu, H., & Wang, Y. (2022) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-022-09802-2 · Cited by 13
Verma, M., Gall, L., Biasetti, J., Veroli, G. Y. D., Pichardo‐Almarza, C., Gibbs, M. A., & Kimko, H. H. C. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2022.1063308 · Cited by 13
Osipova, N., Budko, A., Maksimenko, O., Шипуло, Е. В., Vanchugova, L. V., Chen, W., Gelperina, S. E., & Wacker, M. G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041258 · Cited by 13
Enhancing population pharmacokinetic modeling efficiency and quality using an integrated workflow
Schmidt, H., & Radivojevic, A. (2014) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-014-9370-4 · Cited by 12
European Regulatory Perspective on Pediatric Physiologically Based Pharmacokinetic Models
Cole, S. M., Hay, J. L., Luzon, E., Nordmark, A., & Rusten, I. S. (2017) · International Journal of Pharmacokinetics · doi:10.4155/ipk-2016-0025 · Cited by 12
Harun, R., Yang, E., Kassir, N., Zhang, W., & Lu, J. J.-Q. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051381 · Cited by 12
Marques, L., & Vale, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061586 · Cited by 11
Self-citationLi, A., Mak, W. Y., Ruan, T., Dong, F., Zheng, N., Gu, M., Guo, W., Zhang, J., Cheng, H., Ruan, C., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1215065 · Cited by 10
Pharmacometrics: The Already-Present Future of Precision Pharmacology
Bandeira, L. C., Pinto, L., & Carneiro, C. M. (2022) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-022-00439-4 · Cited by 9
Amaeze, O. U., & Isoherranen, N. (2023) · Clinical and Translational Science · doi:10.1111/cts.13614 · Cited by 8
Patient-Specific Explanations for Predictions of Clinical Outcomes
Tajgardoon, M., Samayamuthu, M. J., Calzoni, L., & Visweswaran, S. (2019) · ACI Open · doi:10.1055/s-0039-1697907 · Cited by 7
Zhang, N., Chan, M. L., Li, J., Brohawn, P. Z., Sun, B., Vainshtein, I., Roskos, L. K., Faggioni, R., & Savić, R. M. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13044 · Cited by 7
He, S., Zhao, J., Bian, J., Zhao, Y., Li, Y., Guo, N., Hu, L., Liu, B., Shao, Q.-H., He, H., et al. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03603-z · Cited by 7
The omics revolution: beyond genomics. A meeting report
Nice, E. C. (2020) · Clinical Proteomics · doi:10.1186/s12014-020-9266-9 · Cited by 5
Cited by
Ponce‐Bobadilla, A. V., Schmitt, V., Maier, C. S., Mensing, S., & Stodtmann, S. (2024) · Clinical and Translational Science · doi:10.1111/cts.70056 · Cited by 826
Serrano, D. R., Luciano, F. C., Anaya, B. J., Ongoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101328 · Cited by 488
Metadata
- Authors
- Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalhães, P., Schmidt, S., & Vale, N.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2024-02-27
- Volume
- 16
- Issue
- 3
- Pages
- 332
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W4392201174
- Cited by
- 390
- References
- 201
- FWCI
- 31.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.